clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tulassay Z et al. | Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. | 2010 | Scand. J. Gastroenterol. | pmid:20509752 |
| Marignani M et al. | Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. | 1997 | Scand. J. Gastroenterol. | pmid:9200297 |
| Valooran GJ et al. | Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. | 2011 | Scand. J. Gastroenterol. | pmid:21627398 |
| Kajihara Y et al. | Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. | 2017 | Scand. J. Gastroenterol. | pmid:27806639 |
| Ogura K et al. | Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? | 2001 | Scand. J. Gastroenterol. | pmid:11424316 |
| Masuda H et al. | Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. | 2003 | Scand. J. Gastroenterol. | pmid:14531530 |
| Ellenrieder V et al. | Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. | 1999 | Scand. J. Gastroenterol. | pmid:10499474 |
| Ochi M et al. | Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin. | 2006 | Scand. J. Gastroenterol. | pmid:16497629 |
| Unge P et al. | Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features? | 2003 | Scand. J. Gastroenterol. | pmid:12795457 |
| de Boer WA and Tytgat GN | The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? | 1995 | Scand. J. Gastroenterol. | pmid:7638563 |
| Seppälä K et al. | Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects. | 2008 | Scand. J. Gastroenterol. | pmid:18609180 |
| Khan Z et al. | Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study. | 2002 | Scand. J. Gastroenterol. | pmid:11843048 |
| Gasbarrini A et al. | Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. | 2000 | Scand. J. Gastroenterol. | pmid:10766318 |
| Fiorini G et al. | Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016. | 2018 | Scand. J. Gastroenterol. | pmid:29688095 |
| Zevit N et al. | Antibiotic resistance of Helicobacter pylori in Israeli children. | 2010 | Scand. J. Gastroenterol. | pmid:20199338 |
| Abut E et al. | Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study. | 2010 | Scand. J. Gastroenterol. | pmid:20334478 |
| Li H et al. | Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study. | 2018 | Scand. J. Gastroenterol. | pmid:29214879 |
| Lindsetmo RO et al. | Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy. | 1998 | Scand. J. Gastroenterol. | pmid:9548613 |
| Raymond J et al. | Diagnosis of Helicobacter pylori recurrence: relapse or reinfection? Usefulness of molecular tools. | 2016 | Scand. J. Gastroenterol. | pmid:26784882 |
| Lerang F et al. | Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. | 1997 | Scand. J. Gastroenterol. | pmid:9438318 |
| Seppälä K et al. | Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. | 2000 | Scand. J. Gastroenterol. | pmid:11063151 |
| Higashida A et al. | Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan. | 2013 | Scand. J. Gastroenterol. | pmid:23016956 |
| Testoni PA and Bagnolo F | In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern. | 2000 | Scand. J. Gastroenterol. | pmid:10994618 |
| Di Giulio M et al. | In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. | 2016 | Scand. J. Gastroenterol. | pmid:26554617 |
| Lee JW et al. | A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. | 2014 | Scand. J. Gastroenterol. | pmid:24988873 |
| Cellini L et al. | Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. | 2006 | Scand. J. Gastroenterol. | pmid:16497614 |
| Lee JW et al. | GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea. | 2014 | Scand. J. Gastroenterol. | pmid:24957849 |
| Gisbert JP et al. | Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection. | 2013 | Scand. J. Gastroenterol. | pmid:23556551 |
| Gisbert JP et al. | Unhealed duodenal ulcers despite Helicobacter pylori eradication. | 1997 | Scand. J. Gastroenterol. | pmid:9246702 |
| Parente F et al. | Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. | 1998 | Scand. J. Gastroenterol. | pmid:9648983 |
| Apostolopoulos P et al. | Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. | 2016 | Scand. J. Gastroenterol. | pmid:26435055 |
| Doorakkers E et al. | Helicobacter pylori eradication in the Swedish population. | Scand. J. Gastroenterol. | pmid:28323552 | |
| Tsukada K et al. | Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients. | 2002 | Scand. J. Gastroenterol. | pmid:12465723 |
| Murakami K et al. | Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study. | 2011 | Scand. J. Gastroenterol. | pmid:21073372 |
| Ribaldone DG et al. | Helicobacter pylori eradication: poor medical compliance from East to West of the world. | 2018 | Scand. J. Gastroenterol. | pmid:29383955 |
| Farup PG et al. | Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. | 2002 | Scand. J. Gastroenterol. | pmid:12523585 |
| Bjerre M et al. | Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. | 2014 | Scand. J. Clin. Lab. Invest. | pmid:25026506 |
| Paakkanen R et al. | Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies. | 2009 | Scand. Cardiovasc. J. | pmid:19365786 |
| Alfaresi MS et al. | Molecular prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori in the United Arab Emirates. | 2005 | Saudi Med J | pmid:15951866 |
| Ghazzawi IM et al. | Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. | 2004 | Saudi Med J | pmid:15322588 |
| Al-Mobeireek AF | Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease. | 2002 | Saudi Med J | pmid:12174240 |
| Celen MK et al. | Development of pneumatoceles after viral infection. | 2006 | Saudi Med J | pmid:16830037 |
| Bindayna KM | Antibiotic susceptibilities of Helicobacter pylori. | 2001 | Saudi Med J | pmid:11255612 |
| Ranganathan D et al. | Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. | 2013 | Saudi J Kidney Dis Transpl | pmid:24029271 |
| Vafaeimanesh J et al. | Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. | 2014 | Saudi J Kidney Dis Transpl | pmid:24434382 |
| Alsohaibani F et al. | Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection. | Saudi J Gastroenterol | pmid:26228365 | |
| Zullo A et al. | Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis. | Saudi J Gastroenterol | pmid:22249086 | |
| Agah S et al. | Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. | 2009 Oct-Dec | Saudi J Gastroenterol | pmid:19794266 |
| Kekilli M et al. | Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori. | Saudi J Gastroenterol | pmid:27748322 | |
| Rajendiran S et al. | Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. | 2012 Jul-Aug | Saudi J Gastroenterol | pmid:22824768 |
| Hu JL et al. | Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China. | Saudi J Gastroenterol | pmid:28937021 | |
| Abadi AT et al. | High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. | 2011 Nov-Dec | Saudi J Gastroenterol | pmid:22064338 |
| Dajani AI et al. | Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? | 2013 May-Jun | Saudi J Gastroenterol | pmid:23680708 |
| Zhang SH et al. | The effect of virulence genotypes of on eradication therapy in children. | Saudi J Gastroenterol | pmid:29652033 | |
| Al Majid FM | Peritonitis due to Mycobacterium fortuitum following gastric banding. | Saudi J Gastroenterol | pmid:20339182 | |
| Shokrzadeh L et al. | Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. | Saudi J Gastroenterol | pmid:21727733 | |
| Hasan SR et al. | Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. | Saudi J Gastroenterol | pmid:20065568 | |
| Khan MQ | Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. | 2008 | Saudi J Gastroenterol | pmid:19568511 |
| Wang J et al. | Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study. | Saudi J Gastroenterol | pmid:26655129 | |
| Pellicano R and Fagoonee S | One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015? | Saudi J Gastroenterol | pmid:26655127 | |
| Dajani A et al. | Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease. | Saudi J Gastroenterol | pmid:19858579 | |
| Salem EM et al. | Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. | 2010 Jul-Sep | Saudi J Gastroenterol | pmid:20616418 |
| Bezmin Abadi AT et al. | Inefficiency of rapid urease test for confirmation of Helicobacter pylori. | Saudi J Gastroenterol | pmid:21196663 | |
| Rajindrajith S et al. | Helicobacter pylori infection in children. | 2009 | Saudi J Gastroenterol | pmid:19568571 |
| Baba K et al. | A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. | 2006 | Sarcoidosis Vasc Diffuse Lung Dis | pmid:16933475 |
| Bellelis P et al. | Efficacy of a triple therapy for Helicobacter pylori eradication in a well-developed urban area in Brazil. | 2004 | Sao Paulo Med J | pmid:15257365 |
| Eisig JN et al. | Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. | 2003 | Sao Paulo Med J | pmid:12751338 |
| Kimang'a AN et al. | Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans. | 2010 | S. Afr. Med. J. | pmid:20429490 |
| Laving A et al. | Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya. | 2013 | S. Afr. Med. J. | pmid:24300630 |
| Sakatani M | [Multi-drug resistant mycobacterial infection]. | 1999 | Ryoikibetsu Shokogun Shirizu | pmid:10088372 |
| AIDS patients have a new weapon against MAC infection. | 1994 | RN | pmid:8128150 | |
| Fujikawa K et al. | [A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. | 2006 | Rinsho Shinkeigaku | pmid:17061701 |
| Ohe M and Kohno M | [Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment]. | 2003 | Rinsho Ketsueki | pmid:14639954 |
| Goto H et al. | [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. | 2001 | Rinsho Ketsueki | pmid:11828723 |
| Sakabe H et al. | [Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. | 2004 | Rinsho Ketsueki | pmid:15199751 |
| MORITA R et al. | Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. | 2009 | Rinsho Ketsueki | pmid:20009444 |
| Yanagimachi M et al. | [Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation]. | 2008 | Rinsho Ketsueki | pmid:18341040 |
| Takahashi T et al. | [Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura]. | 2006 | Rinsho Ketsueki | pmid:16784096 |
| Ohe M and Hashino S | [Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS]. | 2010 | Rinsho Ketsueki | pmid:20467229 |
| Yamane N et al. | [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria]. | 2002 | Rinsho Byori | pmid:12014018 |
| Ozawa S | [Drug-drug interaction in pharmacogenetics and pharmacogenomics]. | 2002 | Rinsho Byori | pmid:11925851 |
| Tomita A et al. | [Analysis of the macrolide resistance gene in penicillin-resistant Streptococcus pneumoniae]. | 2006 | Rinsho Byori | pmid:16989397 |
| Egashira T | [Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori]. | 2006 | Rinsho Byori | pmid:16548239 |
| Kodama M and Fujioka T | [Eradication therapy of Helicobacter pylori infection]. | 2001 | Rinsho Byori | pmid:11307304 |
| Fukuda Y et al. | [The history of Helicobacter pylori]. | 2001 | Rinsho Byori | pmid:11307300 |
| Chen G et al. | [The cause of failure of eradication treatment of Helicobacter pylori]. | 2005 | Rinsho Byori | pmid:16190353 |
| Murata Y et al. | [Study on the detection methods of Helicobacter pylori from clinical specimens]. | 2002 | Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi | pmid:11895427 |
| Cervin A and Wallwork B | Macrolide therapy of chronic rhinosinusitis. | 2007 | Rhinology | pmid:18085018 |
| Stefansson P et al. | Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. | 1998 | Rhinology | pmid:9923060 |
| Haruna S et al. | A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. | 2009 | Rhinology | pmid:19382498 |
| Furuya H et al. | SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. | 2017 | Rheumatology (Oxford) | pmid:28371927 |
| Andereya S et al. | Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila. | 2004 | Rheumatol. Int. | pmid:14513269 |
| Cohen O et al. | Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. | 2015 | Rheumatol. Int. | pmid:26210999 |
| Saviola G et al. | Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study. | 2013 | Rheumatol. Int. | pmid:23864141 |
| Breda L et al. | Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. | 2009 | Rheumatol. Int. | pmid:19156420 |
| Saviola G et al. | Clarithromycin in adult-onset Still's disease: a study of 6 cases. | 2010 | Rheumatol. Int. | pmid:20033412 |
| O'Connor MB et al. | Rituximab-induced pulmonary disease. | 2012 | Rheumatol. Int. | pmid:21892654 |
| Haj Yahia S et al. | Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. | 2018 | Rheumatol. Int. | pmid:28975396 |
| Caliskan R et al. | Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. | Rev. Soc. Bras. Med. Trop. | pmid:26108005 | |
| Paina FA et al. | [Hematological, hemostatic and biochemical alterations induced by clofazimine and clarithromycin, in single and multiple doses, in rats]. | 2008 May-Jun | Rev. Soc. Bras. Med. Trop. | pmid:18719809 |